img

Global OTC Anti-Infective Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global OTC Anti-Infective Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Anti-infectives are medicines that work to prevent or treat infections.
OTC Anti-Infective Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global OTC Anti-Infective Drug market is projected to reach US$ 37880 million in 2029, increasing from US$ 22510 million in 2022, with the CAGR of 8.3% during the period of 2024 to 2029. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
The Over-the-Counter (OTC) Anti-Infective Drug market has grown as a convenient option for consumers seeking self-treatment for minor infections. These drugs, available without a prescription, include topical ointments, creams, and oral medications for conditions like skin infections, cold sores, and vaginal infections. The market's expansion is driven by the demand for accessible and cost-effective solutions to address common infections without the need for a doctor's visit. As awareness of self-care and health empowerment increases, the OTC Anti-Infective Drug market continues to offer a range of effective options that enable individuals to manage mild infections quickly and conveniently.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global OTC Anti-Infective Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Bayer
GSK
Teva
Johnson & Johnson
NOVARTIS
MYLAN
Sun Pharma
CR SANJIU
Cipla
Lingrui
Segment by Type
Antifungal
Antibacterial
Antiviral
Antiseptics
Other

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the OTC Anti-Infective Drug market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, OTC Anti-Infective Drug introduction, etc. OTC Anti-Infective Drug Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of OTC Anti-Infective Drug market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of OTC Anti-Infective Drug
1.1 OTC Anti-Infective Drug Market Overview
1.1.1 OTC Anti-Infective Drug Product Scope
1.1.2 OTC Anti-Infective Drug Market Status and Outlook
1.2 Global OTC Anti-Infective Drug Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global OTC Anti-Infective Drug Market Size by Region (2018-2029)
1.4 Global OTC Anti-Infective Drug Historic Market Size by Region (2018-2024)
1.5 Global OTC Anti-Infective Drug Market Size Forecast by Region (2024-2029)
1.6 Key Regions, OTC Anti-Infective Drug Market Size (2018-2029)
1.6.1 North America OTC Anti-Infective Drug Market Size (2018-2029)
1.6.2 Europe OTC Anti-Infective Drug Market Size (2018-2029)
1.6.3 Asia-Pacific OTC Anti-Infective Drug Market Size (2018-2029)
1.6.4 Latin America OTC Anti-Infective Drug Market Size (2018-2029)
1.6.5 Middle East & Africa OTC Anti-Infective Drug Market Size (2018-2029)
2 OTC Anti-Infective Drug Market by Type
2.1 Introduction
2.1.1 Antifungal
2.1.2 Antibacterial
2.1.3 Antiviral
2.1.4 Antiseptics
2.1.5 Other
2.2 Global OTC Anti-Infective Drug Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global OTC Anti-Infective Drug Historic Market Size by Type (2018-2024)
2.2.2 Global OTC Anti-Infective Drug Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America OTC Anti-Infective Drug Revenue Breakdown by Type (2018-2029)
2.3.2 Europe OTC Anti-Infective Drug Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific OTC Anti-Infective Drug Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America OTC Anti-Infective Drug Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa OTC Anti-Infective Drug Revenue Breakdown by Type (2018-2029)
3 OTC Anti-Infective Drug Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global OTC Anti-Infective Drug Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global OTC Anti-Infective Drug Historic Market Size by Application (2018-2024)
3.2.2 Global OTC Anti-Infective Drug Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America OTC Anti-Infective Drug Revenue Breakdown by Application (2018-2029)
3.3.2 Europe OTC Anti-Infective Drug Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific OTC Anti-Infective Drug Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America OTC Anti-Infective Drug Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa OTC Anti-Infective Drug Revenue Breakdown by Application (2018-2029)
4 OTC Anti-Infective Drug Competition Analysis by Players
4.1 Global OTC Anti-Infective Drug Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in OTC Anti-Infective Drug as of 2022)
4.3 Date of Key Players Enter into OTC Anti-Infective Drug Market
4.4 Global Top Players OTC Anti-Infective Drug Headquarters and Area Served
4.5 Key Players OTC Anti-Infective Drug Product Solution and Service
4.6 Competitive Status
4.6.1 OTC Anti-Infective Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bayer
5.1.1 Bayer Profile
5.1.2 Bayer Main Business
5.1.3 Bayer OTC Anti-Infective Drug Products, Services and Solutions
5.1.4 Bayer OTC Anti-Infective Drug Revenue (US$ Million) & (2018-2024)
5.1.5 Bayer Recent Developments
5.2 GSK
5.2.1 GSK Profile
5.2.2 GSK Main Business
5.2.3 GSK OTC Anti-Infective Drug Products, Services and Solutions
5.2.4 GSK OTC Anti-Infective Drug Revenue (US$ Million) & (2018-2024)
5.2.5 GSK Recent Developments
5.3 Teva
5.3.1 Teva Profile
5.3.2 Teva Main Business
5.3.3 Teva OTC Anti-Infective Drug Products, Services and Solutions
5.3.4 Teva OTC Anti-Infective Drug Revenue (US$ Million) & (2018-2024)
5.3.5 Johnson & Johnson Recent Developments
5.4 Johnson & Johnson
5.4.1 Johnson & Johnson Profile
5.4.2 Johnson & Johnson Main Business
5.4.3 Johnson & Johnson OTC Anti-Infective Drug Products, Services and Solutions
5.4.4 Johnson & Johnson OTC Anti-Infective Drug Revenue (US$ Million) & (2018-2024)
5.4.5 Johnson & Johnson Recent Developments
5.5 NOVARTIS
5.5.1 NOVARTIS Profile
5.5.2 NOVARTIS Main Business
5.5.3 NOVARTIS OTC Anti-Infective Drug Products, Services and Solutions
5.5.4 NOVARTIS OTC Anti-Infective Drug Revenue (US$ Million) & (2018-2024)
5.5.5 NOVARTIS Recent Developments
5.6 MYLAN
5.6.1 MYLAN Profile
5.6.2 MYLAN Main Business
5.6.3 MYLAN OTC Anti-Infective Drug Products, Services and Solutions
5.6.4 MYLAN OTC Anti-Infective Drug Revenue (US$ Million) & (2018-2024)
5.6.5 MYLAN Recent Developments
5.7 Sun Pharma
5.7.1 Sun Pharma Profile
5.7.2 Sun Pharma Main Business
5.7.3 Sun Pharma OTC Anti-Infective Drug Products, Services and Solutions
5.7.4 Sun Pharma OTC Anti-Infective Drug Revenue (US$ Million) & (2018-2024)
5.7.5 Sun Pharma Recent Developments
5.8 CR SANJIU
5.8.1 CR SANJIU Profile
5.8.2 CR SANJIU Main Business
5.8.3 CR SANJIU OTC Anti-Infective Drug Products, Services and Solutions
5.8.4 CR SANJIU OTC Anti-Infective Drug Revenue (US$ Million) & (2018-2024)
5.8.5 CR SANJIU Recent Developments
5.9 Cipla
5.9.1 Cipla Profile
5.9.2 Cipla Main Business
5.9.3 Cipla OTC Anti-Infective Drug Products, Services and Solutions
5.9.4 Cipla OTC Anti-Infective Drug Revenue (US$ Million) & (2018-2024)
5.9.5 Cipla Recent Developments
5.10 Lingrui
5.10.1 Lingrui Profile
5.10.2 Lingrui Main Business
5.10.3 Lingrui OTC Anti-Infective Drug Products, Services and Solutions
5.10.4 Lingrui OTC Anti-Infective Drug Revenue (US$ Million) & (2018-2024)
5.10.5 Lingrui Recent Developments
6 North America
6.1 North America OTC Anti-Infective Drug Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe OTC Anti-Infective Drug Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific OTC Anti-Infective Drug Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America OTC Anti-Infective Drug Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 OTC Anti-Infective Drug Market Dynamics
11.1 OTC Anti-Infective Drug Industry Trends
11.2 OTC Anti-Infective Drug Market Drivers
11.3 OTC Anti-Infective Drug Market Challenges
11.4 OTC Anti-Infective Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market OTC Anti-Infective Drug Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global OTC Anti-Infective Drug Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global OTC Anti-Infective Drug Market Size Share by Region (2018-2024)
Table 4. Global OTC Anti-Infective Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global OTC Anti-Infective Drug Forecasted Market Size Share by Region (2024-2029)
Table 6. Global OTC Anti-Infective Drug Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global OTC Anti-Infective Drug Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global OTC Anti-Infective Drug Revenue Market Share by Type (2018-2024)
Table 9. Global OTC Anti-Infective Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global OTC Anti-Infective Drug Revenue Market Share by Type (2024-2029)
Table 11. North America OTC Anti-Infective Drug Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America OTC Anti-Infective Drug Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe OTC Anti-Infective Drug Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe OTC Anti-Infective Drug Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific OTC Anti-Infective Drug Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific OTC Anti-Infective Drug Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America OTC Anti-Infective Drug Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America OTC Anti-Infective Drug Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa OTC Anti-Infective Drug Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa OTC Anti-Infective Drug Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global OTC Anti-Infective Drug Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global OTC Anti-Infective Drug Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global OTC Anti-Infective Drug Revenue Market Share by Application (2018-2024)
Table 24. Global OTC Anti-Infective Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global OTC Anti-Infective Drug Revenue Market Share by Application (2024-2029)
Table 26. North America OTC Anti-Infective Drug Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America OTC Anti-Infective Drug Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe OTC Anti-Infective Drug Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe OTC Anti-Infective Drug Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific OTC Anti-Infective Drug Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific OTC Anti-Infective Drug Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America OTC Anti-Infective Drug Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America OTC Anti-Infective Drug Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa OTC Anti-Infective Drug Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa OTC Anti-Infective Drug Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global OTC Anti-Infective Drug Revenue (US$ Million) by Players (2018-2024)
Table 37. Global OTC Anti-Infective Drug Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in OTC Anti-Infective Drug as of 2022)
Table 39. Date of Key Players Enter into OTC Anti-Infective Drug Market
Table 40. Global OTC Anti-Infective Drug Key Players Headquarters and Area Served
Table 41. OTC Anti-Infective Drug Product Solution and Service
Table 42. Global OTC Anti-Infective Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Bayer Basic Information List
Table 45. Bayer Description and Business Overview
Table 46. Bayer OTC Anti-Infective Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in OTC Anti-Infective Drug Business of Bayer (2018-2024)
Table 48. Bayer Recent Developments
Table 49. GSK Basic Information List
Table 50. GSK Description and Business Overview
Table 51. GSK OTC Anti-Infective Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in OTC Anti-Infective Drug Business of GSK (2018-2024)
Table 53. GSK Recent Developments
Table 54. Teva Basic Information List
Table 55. Teva Description and Business Overview
Table 56. Teva OTC Anti-Infective Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in OTC Anti-Infective Drug Business of Teva (2018-2024)
Table 58. Teva Recent Developments
Table 59. Johnson & Johnson Basic Information List
Table 60. Johnson & Johnson Description and Business Overview
Table 61. Johnson & Johnson OTC Anti-Infective Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in OTC Anti-Infective Drug Business of Johnson & Johnson (2018-2024)
Table 63. Johnson & Johnson Recent Developments
Table 64. NOVARTIS Basic Information List
Table 65. NOVARTIS Description and Business Overview
Table 66. NOVARTIS OTC Anti-Infective Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in OTC Anti-Infective Drug Business of NOVARTIS (2018-2024)
Table 68. NOVARTIS Recent Developments
Table 69. MYLAN Basic Information List
Table 70. MYLAN Description and Business Overview
Table 71. MYLAN OTC Anti-Infective Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in OTC Anti-Infective Drug Business of MYLAN (2018-2024)
Table 73. MYLAN Recent Developments
Table 74. Sun Pharma Basic Information List
Table 75. Sun Pharma Description and Business Overview
Table 76. Sun Pharma OTC Anti-Infective Drug Products, Services and Solutions
Table 77. Revenue (US$ Million) in OTC Anti-Infective Drug Business of Sun Pharma (2018-2024)
Table 78. Sun Pharma Recent Developments
Table 79. CR SANJIU Basic Information List
Table 80. CR SANJIU Description and Business Overview
Table 81. CR SANJIU OTC Anti-Infective Drug Products, Services and Solutions
Table 82. Revenue (US$ Million) in OTC Anti-Infective Drug Business of CR SANJIU (2018-2024)
Table 83. CR SANJIU Recent Developments
Table 84. Cipla Basic Information List
Table 85. Cipla Description and Business Overview
Table 86. Cipla OTC Anti-Infective Drug Products, Services and Solutions
Table 87. Revenue (US$ Million) in OTC Anti-Infective Drug Business of Cipla (2018-2024)
Table 88. Cipla Recent Developments
Table 89. Lingrui Basic Information List
Table 90. Lingrui Description and Business Overview
Table 91. Lingrui OTC Anti-Infective Drug Products, Services and Solutions
Table 92. Revenue (US$ Million) in OTC Anti-Infective Drug Business of Lingrui (2018-2024)
Table 93. Lingrui Recent Developments
Table 94. North America OTC Anti-Infective Drug Market Size by Country (2018-2024) & (US$ Million)
Table 95. North America OTC Anti-Infective Drug Market Size by Country (2024-2029) & (US$ Million)
Table 96. Europe OTC Anti-Infective Drug Market Size by Country (2018-2024) & (US$ Million)
Table 97. Europe OTC Anti-Infective Drug Market Size by Country (2024-2029) & (US$ Million)
Table 98. Asia-Pacific OTC Anti-Infective Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 99. Asia-Pacific OTC Anti-Infective Drug Market Size by Region (2018-2024) & (US$ Million)
Table 100. Asia-Pacific OTC Anti-Infective Drug Market Size by Region (2024-2029) & (US$ Million)
Table 101. Asia-Pacific OTC Anti-Infective Drug Market Share by Region (2018-2024)
Table 102. Asia-Pacific OTC Anti-Infective Drug Market Share by Region (2024-2029)
Table 103. Latin America OTC Anti-Infective Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 104. Latin America OTC Anti-Infective Drug Market Size by Country (2018-2024) & (US$ Million)
Table 105. Latin America OTC Anti-Infective Drug Market Size by Country (2024-2029) & (US$ Million)
Table 106. Middle East & Africa OTC Anti-Infective Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 107. Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2018-2024) & (US$ Million)
Table 108. Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2024-2029) & (US$ Million)
Table 109. OTC Anti-Infective Drug Market Trends
Table 110. OTC Anti-Infective Drug Market Drivers
Table 111. OTC Anti-Infective Drug Market Challenges
Table 112. OTC Anti-Infective Drug Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global OTC Anti-Infective Drug Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global OTC Anti-Infective Drug Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global OTC Anti-Infective Drug Market Share by Regions: 2022 VS 2029
Figure 4. Global OTC Anti-Infective Drug Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America OTC Anti-Infective Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe OTC Anti-Infective Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific OTC Anti-Infective Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America OTC Anti-Infective Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa OTC Anti-Infective Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Antifungal
Figure 11. Global Antifungal Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Antibacterial
Figure 13. Global Antibacterial Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Antiviral
Figure 15. Global Antiviral Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Product Picture of Antiseptics
Figure 17. Global Antiseptics Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 18. Product Picture of Other
Figure 19. Global Other Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 20. Global OTC Anti-Infective Drug Market Size Share by Type: 2022 & 2029
Figure 21. North America OTC Anti-Infective Drug Revenue Market Share by Type (2018-2029)
Figure 22. Europe OTC Anti-Infective Drug Revenue Market Share by Type (2018-2029)
Figure 23. Asia-Pacific OTC Anti-Infective Drug Revenue Market Share by Type (2018-2029)
Figure 24. Latin America OTC Anti-Infective Drug Revenue Market Share by Type (2018-2029)
Figure 25. Middle East and Africa OTC Anti-Infective Drug Revenue Market Share by Type (2018-2029)
Figure 26. Hospital Pharmacies Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 27. Retail Pharmacies Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 28. Online Pharmacies Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 29. Global OTC Anti-Infective Drug Market Size Share by Application: 2022 & 2029
Figure 30. North America OTC Anti-Infective Drug Revenue Market Share by Application (2018-2029)
Figure 31. Europe OTC Anti-Infective Drug Revenue Market Share by Application (2018-2029)
Figure 32. Asia-Pacific OTC Anti-Infective Drug Revenue Market Share by Application (2018-2029)
Figure 33. Latin America OTC Anti-Infective Drug Revenue Market Share by Application (2018-2029)
Figure 34. Middle East and Africa OTC Anti-Infective Drug Revenue Market Share by Application (2018-2029)
Figure 35. OTC Anti-Infective Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 36. Global Top 5 and Top 10 Players OTC Anti-Infective Drug Market Share in 2022
Figure 37. North America OTC Anti-Infective Drug Market Share by Country (2018-2029)
Figure 38. United States OTC Anti-Infective Drug Market Size (2018-2029) & (US$ Million)
Figure 39. Canada OTC Anti-Infective Drug Market Size (2018-2029) & (US$ Million)
Figure 40. Germany OTC Anti-Infective Drug Market Size (2018-2029) & (US$ Million)
Figure 41. France OTC Anti-Infective Drug Market Size (2018-2029) & (US$ Million)
Figure 42. U.K. OTC Anti-Infective Drug Market Size (2018-2029) & (US$ Million)
Figure 43. Italy OTC Anti-Infective Drug Market Size (2018-2029) & (US$ Million)
Figure 44. Russia OTC Anti-Infective Drug Market Size (2018-2029) & (US$ Million)
Figure 45. Nordic Countries OTC Anti-Infective Drug Market Size (2018-2029) & (US$ Million)
Figure 46. Asia-Pacific OTC Anti-Infective Drug Market Share by Region (2018-2029)
Figure 47. China OTC Anti-Infective Drug Market Size (2018-2029) & (US$ Million)
Figure 48. Japan OTC Anti-Infective Drug Market Size (2018-2029) & (US$ Million)
Figure 49. South Korea OTC Anti-Infective Drug Market Size (2018-2029) & (US$ Million)
Figure 50. Southeast Asia OTC Anti-Infective Drug Market Size (2018-2029) & (US$ Million)
Figure 51. India OTC Anti-Infective Drug Market Size (2018-2029) & (US$ Million)
Figure 52. Australia OTC Anti-Infective Drug Market Size (2018-2029) & (US$ Million)
Figure 53. Latin America OTC Anti-Infective Drug Market Share by Country (2018-2029)
Figure 54. Mexico OTC Anti-Infective Drug Market Size (2018-2029) & (US$ Million)
Figure 55. Brazil OTC Anti-Infective Drug Market Size (2018-2029) & (US$ Million)
Figure 56. Middle East & Africa OTC Anti-Infective Drug Market Share by Country (2018-2029)
Figure 57. Turkey OTC Anti-Infective Drug Market Size (2018-2029) & (US$ Million)
Figure 58. Saudi Arabia OTC Anti-Infective Drug Market Size (2018-2029) & (US$ Million)
Figure 59. UAE OTC Anti-Infective Drug Market Size (2018-2029) & (US$ Million)
Figure 60. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries